These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Comparison between heparin and a heparin analogue (sodium pentosan polysulphate) in the initial treatment of deep vein thrombosis. Preliminary communication. Bergqvist D; Falke P; Jaroszewski H; Lamme S Vasa; 1986; 15(1):77-80. PubMed ID: 2421498 [No Abstract] [Full Text] [Related]
27. Thrombocytopenia with or without thrombosis after pentosan polysulfate treatment. Claisse JF; Andrejak M; Jarry G; Desablens B; Roussel B; Delobel J Therapie; 1990; 45(6):514-5. PubMed ID: 1706895 [No Abstract] [Full Text] [Related]
28. [Does the pentosan polysulfate-heparin have a thrombolytic action?]. Pinot JJ; Sampol J Presse Med; 1986 Oct; 15(33):1683. PubMed ID: 2431405 [No Abstract] [Full Text] [Related]
33. Release of plasminogen activator by pentosan polysulphate. Klöcking HP; Markwardt F Thromb Res; 1986 Mar; 41(5):739-44. PubMed ID: 2421436 [No Abstract] [Full Text] [Related]
34. Fibrinogen binding on human platelets. Influence of different heparins and of pentosane polysulfate. Dunn F; Soria J; Soria C; Thomaidis A; Tobelem G; Caen JP Thromb Res; 1983 Jan; 29(2):141-8. PubMed ID: 6189236 [TBL] [Abstract][Full Text] [Related]
35. Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54). Scully MF; Kakkar VV Thromb Res; 1984 Oct; 36(2):187-94. PubMed ID: 6209821 [TBL] [Abstract][Full Text] [Related]
36. Tolerance to the synthetic pentasaccharide fondaparinux in heparin sensitization. Sacher C; Hunzelmann N Allergy; 2003 Dec; 58(12):1318-9. PubMed ID: 14616114 [No Abstract] [Full Text] [Related]
37. Heparin-related immune thrombocytopenia. Studies of antibody-heparin specificity. Trowbridge AA; Caraveo J; Green JB; Amaral B; Stone MJ Am J Med; 1978 Aug; 65(2):277-83. PubMed ID: 80131 [No Abstract] [Full Text] [Related]